A new drug is offering dramatic cure rates for hepatitis C patients with two subtypes of the infection -- genotype 2 and 3, say a team of scientists. The drug, called sofosbuvir, offers more effective ...

Patients chronically infected with hepatitis C virus (HCV) genotype 2 or 3 for whom treatment with peginterferon is not an option, or who have not had a response to prior interferon treatment, ...

Two independent studies of children in the UK who developed unexplained liver damage, or hepatitis, have found a virus called adeno-associated virus 2 in nearly all of them, but not in other similar ...